DrugShortagePulse: Manufacturer discontinuation
78 drugShortagePulse: Manufacturer discontinuation are listed from openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list), dated 2026-05-05 to 2026-10-30; the most frequent is Fresenius Kabi USA, LLC with 7. Data last updated 2026-11-04; each record links to its official source and a full report.
Data as of · Compiled by Zalwin from openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list)
Includes: Manufacturer, Drug, Stage, Availability, Updated, official source URL and score · Card, Apple Pay, Google Pay or Link via Stripe
78 records from openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list), dated 2026-05-05 to 2026-10-30. Most frequent: Fresenius Kabi USA, LLC (7). Each record links to a full report and the official source.
Last updated 2026-11-04. Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list).
Get new DrugShortagePulse records by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
- Fresenius Kabi USA, LLC (7)
- Padagis US LLC (7)
- Pfizer Inc. (5)
- Teva Pharmaceuticals USA, Inc. (5)
- Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) (4)
How do I get new drugShortagePulse: Manufacturer discontinuation by email?
Search, filter and export these records, or get alerts when new ones appear.
What are the top drugShortagePulse: Manufacturer discontinuation right now?
| Record | Drug | Stage | Availability |
|---|---|---|---|
| Baxter Healthcare | Cefazolin in Dextrose Injection | Manufacturer discontinuation | |
| Baxter Healthcare | Ceftriaxone Sodium Injection | Manufacturer discontinuation | |
| Baxter Healthcare | Cefepime Hydrochloride Injection | Manufacturer discontinuation | |
| Sanofi-Aventis U.S. LLC | Enoxaparin Sodium Injection | Manufacturer discontinuation | |
| Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | Dexmedetomidine Hydrochloride Injection | Manufacturer discontinuation | |
| Fresenius Kabi USA, LLC | Arsenic Trioxide Injection | Manufacturer discontinuation | |
| Fresenius Kabi USA, LLC | Melphalan Hydrochloride Injection | Manufacturer discontinuation | |
| Par Health, USA LLC | Micafungin Sodium Injection | Manufacturer discontinuation | |
| Hospira, Inc., a Pfizer Company | Cisatracurium Besylate Injection | Manufacturer discontinuation | |
| Merck Sharp & Dohme LLC | Imipenem Anhydrous, Cilastatin, and Relebactam Anhydrous Injection | Manufacturer discontinuation | |
| Eli Lilly and Co. | Insulin Lispro Injection | Manufacturer discontinuation | |
| Eli Lilly and Co. | Insulin Lispro Protamine and Insulin Lispro Injection | Manufacturer discontinuation | |
| Eli Lilly and Co. | Insulin Glargine-aglr Injection | Manufacturer discontinuation | |
| Fresenius Kabi USA, LLC | Potassium Chloride, Sodium Chloride, Calcium Chloride, and Magnesium Chloride Injection, Solution | Manufacturer discontinuation | |
| Novo Nordisk, Inc. | Liraglutide Injection | Manufacturer discontinuation | |
| Fresenius Kabi USA, LLC | 🔒 Unlock all 78 records → | ||
| Vantive US Healthcare LLC | 🔒 Unlock all 78 records → | ||
| Fresenius Kabi USA, LLC | 🔒 Unlock all 78 records → | ||
Browse 35 more matching record reports
- Fresenius Kabi USA, LLC
- Vantive US Healthcare LLC
- Fresenius Kabi USA, LLC
- Cephalon, LLC (a wholly owned subsidiary of Teva Pharmaceutical Industries, Ltd.)
- Fresenius Kabi USA, LLC
- Hospira, Inc., a Pfizer Company
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
- Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Pfizer Inc.
- Teyro Labs
- Accord Healthcare Inc.
- Genentech, Inc
- Mylan Institutional, a Viatris Company
- Teva Pharmaceuticals USA, Inc.
- Fresenius Kabi USA, LLC
- Kindos Pharmaceuticals Co. Ltd.
- Sandoz Inc.
- Mylan Pharmaceuticals Inc., a Viatris Company
- Merck Sharp & Dohme LLC
- ViiV Healthcare Company
- Hikma Pharmaceuticals USA, Inc.
- Par Health, USA LLC
- Par Health, USA LLC
- Par Health, USA LLC
- Teva Pharmaceuticals USA, Inc.
- Merck Sharp & Dohme LLC
- Mylan Pharmaceuticals Inc., a Viatris Company
- Takeda Pharmaceuticals USA Inc.
- Fresenius Medical Care North America
- Amgen Inc.
- Pfizer Inc.
- Teva Pharmaceuticals USA, Inc.
More records in this hub: page 2
Browse all DrugShortagePulse record reports
Which related categories and locations should I check?
Browse by stage
Shortage reverified (still listed) (173) Shortage revised (availability or dates changed) (84) Resolved (10) New shortage posted (8)
Browse by therapeutic category
Anesthesia (73) Cardiovascular (35) Endocrinology/Metabolism (33) Analgesia/Addiction (32) Oncology (32) Psychiatry (32) Anti-Infective (30) Neurology (15) Other (12) Rheumatology (10) Gastroenterology (9) Hematology (9) Dermatology (8) Antiviral (7) Pulmonary/Allergy (5) Medical Imaging (4)
Frequently asked questions
How many drugShortagePulse: Manufacturer discontinuation are listed?
78 records from openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list), last refreshed automatically. The most recent is dated 2026-10-30.
Can I get alerts for Manufacturer discontinuation?
Yes. DrugShortagePulse can email you new records matching this filter; plans are listed on the DrugShortagePulse page.
Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list). Informational only. RSS feed of new records